Despite Controversy, Human Studies of CRISPR Move Forward in the U.S.

The technology that produced a global scandal in China last year has entered into clinical trials to treat sickle cell anemia and an eye disease

Scientific American
Aug 13 · 7 min read
Sickle cell anemia, as seen in a scanning electron micrograph. Photo: Media for Medical/Universal Images Group/Getty Images

By Karen Weintraub

This story is just a click away.

Sign up for a free Medium account to read this story from Scientific American. Plus, get one more story in your member preview this month.
Already have an account? Sign in

Scientific American

Written by

Awesome discoveries. Expert insights. Science that shapes the world.

Scientific American

Awesome discoveries. Expert insights. Science that shapes the world.

Welcome to a place where words matter. On Medium, smart voices and original ideas take center stage - with no ads in sight. Watch
Follow all the topics you care about, and we’ll deliver the best stories for you to your homepage and inbox. Explore
Get unlimited access to the best stories on Medium — and support writers while you’re at it. Just $5/month. Upgrade